StonvexLoading…
StonvexStonvexStonvexCore line items from CTRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $723.17M | $2.98B | $2.12B | $1.27B |
Operating Income | $-4.74M | $92.82M | $55.76M | $19.45M |
Net Income | $-9.53M | $22.39M | $-7.79M | $8.05M |
EPS (Diluted) | $-0.09 | $0.25 | $-0.09 | $-0.11 |
Total Assets | $2.32B | $2.41B | $2.18B | $2.11B |
Total Liabilities | $1.45B | $1.53B | $1.59B | $1.54B |
Cash & Equivalents | $60.34M | $126.63M | $16.13M | $28.33M |
Free Cash Flow OCF − CapEx | $-55.27M | $-8.20M | $-74.51M | $-56.15M |
Shares Outstanding | 100.84M | 100.72M | 88.65M | 88.65M |